John Schlegelmilch, MD to retire as Chief Medical Officer and Office of the President of Cheshire Medical/Dartmouth-Hitchcock
After a career of service to patients and leadership of medical staff in the Monadnock region, John Schlegelmilch, MD will be retiring from his position as Chief Medical Officer and Office of the President of Cheshire Medical Center/Dartmouth Hitchcock Keene on October 15, 2011. Dr. Schlegelmilch has accepted the position of Director Medical Affairs, Rheumatology at Janssen Biotech, a division of Johnson & Johnson. In his new position, Dr.
